Clinical Trial

Improving Learning and Memory in Portuguese Patients With Multiple Sclerosis

Recruiting
View on ClinicalTrials.gov →
Summary
Deficits in memory and learning are common in Multiple Sclerosis, posing significant challenges in patients' daily lives. Cognitive rehabilitation has been shown to be effective in ameliorating these deficits, with programs such as the Modified Story Memory Technique (mSMT). In Portugal, no studies tested the efficacy of memory training programs. We aim to fill that gap by translating and developing mSMT, conducting a randomized double-blind, placebo-control, clinical trial, and, therefore, testing its efficacy through objective measures of cognitive function, and the maintenance of its benefits longitudinally. Patients with documented impairment in new learning abilities will be recruited at Centro Hospitalar Universitario São João, and randomly assigned to a memory retraining group or an active control group. Both groups will undergo baseline, immediate, and long-term follow-up assessments consisting of (1) a neuropsychological comprehensive assessment and (2) self-reported questionnaires regarding symptoms of anxiety, depression, fatigue, quality of life, and sleep. Optional enrollment in pre-post neuroimaging will also allow us to look at changes in the brain.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-04; most recent amendment 2025-02-11.
Status change: Not Yet Recruiting → Recruiting 2024-12-09
Trial Details
NCT Number NCT06723444
Lead Sponsor Centro Hospitalar De São João, E.P.E.
Collaborators: Instituto de Saude Publica da Universidade do Porto, Universidade do Porto
Conditions Multiple Sclerosis
Enrollment 80 participants
Start Date 2024-12-05
Primary Completion 2026-12 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2025-02-12